Summary is the only known physiologic substrate of the interleukin-l[3 (IL-l[3)-converting enzyme (ICE), the founding member of the ICE/ced-3 cell death gene family. Since secreted mature IL-113 has been detected after apoptosis, we investigated whether this cytokine, when produced endogenously, plays a role in ceil death. We found that hypoxiainduced apoptosis can be inhibited by either the IL-1 receptor antagonist (IL-11ka) or by neutralizing antibodies to IL-1 or to its type 1 receptor. IL-1Ra also inhibits apoptosis induced by trophic factor deprivation in primary neurons, as well as by tumor necrosis factor ix in fibroblasts. In addition, during the G1/S phase arrest, mature IL-l[3 induces apoptosis through a pathway independent of CrmA-sensitive gene activity. We also demonstrate that Ice, when expressed in COS cells, requires the coexpression ofpro-IL-l~ for the induction of apoptosis, which is inhibited by IL-1Ra. Interestingly, we found that mature IL-113 has antiapoptotic activity when added exogenously before the onset of hypoxia, which we found is caused in part by its ability to downregulate the IL-1 receptor. Our findings demonstrate that pro-IL-l[3 is a substrate of ICE relevant to cell death, and depending on the temporal cellular commitment to apoptosis, mature IL-1 [3 may function as a positive or negative mediator of cell death.
A Poptosis, a process by which organisms eliminate unwanted cells, is executed through the activation of a tightly regulated program (1) . A genetic pathway of programmed cell death was first identified in the nematode Caenorhabditis elegans. In this worm, the products of the ted-3 and ced-4 genes carry out the program of cellular suicide (2) . IL-l[3-converting enzyme (ICE) 1, a cysteine protease responsible for the activation of pro-interleukin-l[3 (pro-IL-t [3) , is a mammalian homologue of CED-3 (3) (4) (5) . Previous work has demonstrated that Ice overexpression induces programmed cell death, and that mature IL-113 is released during apoptosis mediated via a variety of stimuli (LPS, TNF-IX, and Shigella flexneri infection) (5) (6) (7) (8) . The cowpox virus gene product CrmA, a member of the serpin family and an inhibitor of ICE, prevents apoptosis (5, 7, (9) (10) (11) (12) (13) . Furthermore, the inhibition of apoptosis mediated by CrmA correlates with its inhibition of mature IL-l[3 1Abbreviations used in this paper: DRG, dorsal root ganglia; HU, hydroxyurea; ICE, IL-l~:onverting enzyme; IL-Ra, IL-1 receptor agonist; NGF, nerve growth factor; pro-IL-I [3, prointerleukin-H3. production (7) . Recent reports indicate that TNF-~-induced apoptosis is mediated through a CrmA-inhibitable pathway, suggesting the involvement of the ICE family (7, 14) . The detection of mature IL-113 release during apoptosis strongly suggests that ICE is activated in cell death since in vivo, ICE is the major (if not the only) protease responsible for processing pro-IL-l [3 (15, 16) .
While the critical role of the ICE family in cell death is well accepted, the function of mature IL-l[3 in apoptosis is controversial. Exogenous IL-113 has been shown to induce apoptosis in some systems (17) (18) (19) and to prevent it in others (20, 21) . In this study, we establish a dual functional role for mature IL-113 in ICE-mediated apoptosis. We found that when produced endogenously (i.e., after ICE activation), IL-113 mediates cell death, but when provided exogenously, IL-113 can either stimulate or inhibit cell death. We demonstrate that if IL-l[3 binds to its receptor before exposure to an apoptotic stimulus, it inhibits programmed cell death (by downregulating the IL-1 receptor); in contrast, ifIL-l[3 binds after ICE is activated, it enhances cell death. In addition, we demonstrate that Ice requires the coexpression ofpro-IL-1r to induce apoptosis in COS cells.
Cell death was inhibited by blocking IL-113 from binding to its receptor, indicating that after ICE activation, COS cells required IL-l{3 signal transduction for the completion of the suicide program. Our results demonstrate that endogenously produced mature IL-lf3 plays an integral role in ICE-mediated apoptosis.
Materials and Methods
Hypoxia-inducedApoptosis Assay. HeLa Immunostaining. COS cells (1.5 • 104/chamber) were plated in a poly-L-lysine-coated two-chamber slide and transfected after 12 h, as described above. Cells were fixed after 36 h with 4% paraformaldehyde (15 min), blocked with 1% heat-inactivated goat serum/2% BSA in PBS (2 h), and incubated with a rabbit polyclonal antibody against IL-1 (1:300; Calbiochem-Novabiochem) plus a hybridoma supematant containing a mouse n~lb raised against human ICE (12 h at 4~ Cells were then washed 3X with PBS and incubated with a goat anti-mouse FITClabeled antibody plus a goat anti-rabbit R.ITC-labeled antibody IL-1 R~eptorDownregulation. 1L-1[3 (100 ng/ml) was added as the cells were placed into the hypoxia chamber (90 rain are required to reach oxygen concentrations of 100 ppm). IL-1 receptor-binding assay: HeLa cells (10 e') were seeded in 10-cm dishes and grown overnight. Media was then exchanged containing 1 mg/ml of BSA and 100 ng/ml of 125t-IL-113 at 4~ for I h. After washing twice with cold medium, the cells were incubated with fresh warm medium at 37~ for 0, 30, 60, and 120 rain. Cells were then treated as described above with glycine, and the radioactivity was scored.
Results
Endogenously Produced Mature IL-1~ Plays a Role in a CrmAinhibitable Apoptosis Pathway Induced by Hypoxia. Recently, BCL-2 and p53 have been implicated in hypoxia-mediated, apoptosis (23) (24) (25) . To investigate if the ICE family is involved in hypoxia-induced apoptosis, we tested whether CrmA could inhibit this process. Survival of HeLa cells cultured for 16 h under hypoxic conditions was 10.1%, compared with 69.0% survival of HeLa cells that stably express CrmA (HeLa/CrmA; Fig. 1 a) . Thus, CrmA-inhibitable members of the ICE family play an important role in hypoxia-induced apoptosis. To address whether endogenously produced mature IL-1~3 plays a role in hypoxiainduced cell death, we used several methods to prevent IL-1 from binding to its receptor. We used the IL-1Ra (a naturally occurring cytokine that binds to the IL-1 receptor, blocking IL-l-mediated signal transduction) (26, 27) , an anti-IL-1 polyclonal neutralizing antibody, and an anti-IL-1 type 1 receptor neutralizing mAb (the type 1 receptor mediates IL-1 signal transduction). Each of these reagents inhibited hypoxia-induced cell death, suggesting that hypoxia activates an ICE-like, CrmA-inhibitable pathway, and that endogenously produced mature IL-113 plays a role in hypoxia-induced cell death by binding to the IL-1 type 1 receptor (Fig. 1 a) . We evaluated and confirmed that IL-1R.a indeed blocks 12sI-IL-1-~ binding ( Fig. 1 b) (26, 27) .
Endogenous IL-l fl Mediates Trophic Factor Deprivation-induced Sensory Neuron Apoptosis. W e next investigated in a primary culture system whether endogenous I L -I~ plays a role in apoptosis. D R G neurons undergo apoptosis in culture upon N G F withdrawal (28) . We have previously shown that chicken DI:(G neuronal death induced by trophic factor deprivation is inhibited by CrmA, suggesting involvement of the ICE family (10) . We tested whether endogenously produced mature IL-113, which is produced by neurons in culture (29) , plays a role in trophic factor withdrawal-mediated D R G neuronal apoptosis. Addition of IL-1Ra (100 ng/ml) to newborn mouse D R G neurons inhibited trophic factor withdrawal-induced apoptosis by 69.2 and 37.8% over 24 and 48 h, respectively (Fig. 2) . Inhibition of neuronal apoptosis by IL-1Ra was dose dependent (43.5% in 24 h at a concentration of 40 ng/ml). These results suggest that endogenously produced mature IL-lJ3 plays a role in DI<G neuronal apoptosis after trophic factor withdrawal.
Secreted IL-l fl Mediates TNF-ee-induced Apoptosis of HeLa and L929 Cells. TNF-o~ induces apoptosis via a CrmAinhibitable pathway (7, 14) . In addition, we have demonstrated that mature IL-113 is secreted by TNF-e~-treated cells undergoing apoptosis, suggesting ICE activation during this process (7) . W e tested whether secreted mature IL-1[~ plays a role in TNF-0~-induced apoptosis of L929 cells. IL-1Ra protected L929 cells from TNF-ix-induced death by up to 64.9%, suggesting that secretion and receptor binding of mature IL-l[3 plays a role in TNF-oe-induced cell death (Fig. 3 a) . In addition, HU-treated, G~/S phase--arrested HeLa cells are induced to undergo apoptosis by TNF-0t (22) . Under these conditions, IL-1Ra also inhibited HeLa cell death by 56.0% (Fig. 3 b) . HeLa cells induced to die by TNF-o~ and cyclohexarnide were also protected by IL-1Ra, as well as by three different neutralizing IL-1 antibodies (data not shown). H e L a / C r m A cells were protected from TNF-ix-induced apoptosis by 59.5%, suggesting that an ICE-like activity is involved in the cell death signaling pathway mediated by this cytokine (Fig. 3 b) .
Mature I L -I~ alone does not induce apoptosis of most healthy proliferating cells (including HeLa and L929). To examine if IL-113 would induce cell death in G1/S phasearrested cells, we exposed HU-treated HeLa cells to this cytokine. Indeed, G1/S phase-arrested HeLa cells treated with exogenous IL-113 died in a dose-dependent fashion (83.7% at 100 ng/ml), which was inhibited by the I L -1 R a (Fig. 3 c) . HU-arrested, mature IL-113, and TNF-0~-treated cells underwent typical apoptotic changes of cellular shrinkage, nuclear condensation, and fragmentation (Fig. 3,  d -0. It is interesting that H e L a / C r m A cells were not protected against mature IL-113 as they were against T N F -c i killing, suggesting that mature IL-1t3 induces the apoptotic cascade distal to ICE, and that in H U treated cells, this cytokine causes cell death through an I C E -i n d e p e n d e n t pathway (Fig. 3 c) . This indicates that C r m A is indeed blocking an ICE-like function, and that production and secretion of mature IL-113 is a downstream effector of the apoptotic T N F -o~/ I C E cascade. HeLa cells, however, are required to be primed (in this case with H U arrest) to establish the appropriate intracellular milieu to be sensitized to mature IL-113-induced apoptosis. H U treatment likely mimics intracellular signals that are part o f the apoptotic cascade. (Fig. 4) . Exogenous mature IL-113 did not induce apoptosis in COS cells, indicating that ICE processes additional substrates required for cell death, and that in COS cells, after ICE activation, IL-113 signal transduction is required for the induction of apoptosis. Dual immunofluorescence staining (with anti-ICE and anti-IL-1 antibodies) of COS cells cotransfected with Ice and pro-IL-l~ indicated that only cells expressing both ICE and pro-IL-l~, but not either protein alone, undergo apoptosis (Fig. 5) . W e consistently noticed that the nuclei of cells transfected with Ice were smaller than that of control cells (Fig. 5 c) . These cells 721 Friedlander et al.
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were alive, as demonstrated by their flat morphology and adherence to the plate (Fig. 5 d) , suggesting that ICE initiates the apoptotic process, but requires additional factors (i.e., mature IL-113) for the complete execution of the cell death pathway.
Preincubation of Exogenous IL-1~ Protects Hypoxia-mediated Cell Death by Downregutating the IL-1
Receptor. Conflicting evidence exists regarding the role oflL-11~ in apoptosis. In some systems, IL-113 induces cell death, whereas in others, it inhibits cell death (17) (18) (19) (20) (21) . IL-1I~ inhibition of cell death requires its addition before the apoptotic stimulus, as demonstrated both with TNF-0t killing of L929 cells and with excitatory amino acid-mediated neuronal death (20, 21) . We determined if exogenous mature IL-1 [3 preincubation inhibits cell death in a system where ICE activation and mature I L -I~ receptor binding are important for apoptoffs. HeLa cells preincubated with exogenous IL-113 are markedly protected from hypoxia-induced cell death (10.1 vs. 58.7% survival; Fig. 6 a) . To explain the inhibition of apoptosis by IL-113, we investigated whether preincubation with exogenous IL-113 in our system before exposure to apoptotic stimuli downregulates the IL-1 receptor (34) . Indeed, receptor-binding assays demonstrate that exogenous IL-113 significantly downregulates the IL-1 receptor (Fig. 6  b) . Downregulation of the IL-1 receptor in part explains the protective role of exogenous IL-113, when added before the induction ofapoptosis. The effect oflL-l[3 receptor-binding on apoptosis is dependent on whether ICE is active (enhancing cell death) or inactive (inhibiting cell death, in part by downregulating the IL-1 receptor).
Discussion
The mammalian ICE/Ced-3 family now includes at least six members: ICE, ICH-1/NEDD2, CPP32/Yama/Apopain, TX/ICErellI/ICH-2, ICErelIII, and MCH2 (4, 30, (32) (33) (34) (35) (36) (37) (38) (39) . Since this is a family of proteases whose active site cysteine residue is essential for ICE-mediated apoptosis, their proteolytic activity must be critical in mediating cell death (5) . How might proteolytic cleavage by the ICE family lead to apoptosis? One possibility is that cleavage of a large number of proteins destroys the entire cellular machinery. This is unlikely because most proteins appear to remain intact when cells undergo apoptosis (40) . The second possibility is that proteolytic cleavage of one critically important substrate leads to cell death. This also is unlikely because a number of proteins, including pro-IL-l[3, poly-ADP ribose polymerase (PARP), U1-70 kD ribonuclear protein, and nuclear lamin are cleaved during apoptosis (7, (40) (41) (42) . It is not clear (with the exception of pro-IL-l[3), whether the cleavage products of these proteins mediate downstream events of cell death pathways or whether they are merely the end result ofapoptosis. The third possibility is that activation of the ICE family may result in cleavage of several substrates, some being activated (mediating cell death) and others being destroyed (required for cell survival). The results reported in this study lead us to favor the last hypothesis. Our data indicate that endogenously produced mature IL-1 [3 is directly involved in cell death and is the first identified substrate of an apoptosis-inducing gene whose product plays a direct role in mediating the apoptotic cascade.
A number of signal transduction mechanisms mediate the biological effect of IL-113. Several of these second messengers have been implicated in apoptosis and, after ICE activation, they most likely mediate cell death after endogenous mature IL-113 receptor binding. IL-113 induces ceramide production in EL4 thymoma cells (43) . IL-113 also induces apoptosis in pancreatic RIm5F cells via a pathway that is dependent on its ability to induce nitric oxide production (18) . Both ceramide and nitric oxide are strong candidates for direct mediators of apoptosis (18, 44) . A recent report showed that NGF deprivation of PC12 cells, which induces apoptosis, led to a substantial activation of theJNK and p38 MAP kinases (45) . IL-113 has been shown to activate the JNK-p38--signaling pathway, and NGF withdrawal may induce secretion of IL-113, which then activates the JNK-p38 pathway and cell death (46) . In light of our previous and current reported results, which point to a definite role of ICE in apoptosis, it is intrigning that ICE knockout mice are developmentally normal (15, 16) . To date, the only resistance to apoptosis reported in this mouse is in anti-Fas-mediated thymocyte cell death (16) . On the surface, this would seem to contradict the notion that ICE itself is important in cell death pathways. However, it is not surprising that knocking out only a single member of the ever-growing number of ICE/ced-3 homologues would not produce a striking apoptotic phenotype, considering the redundancy of such an important and terminal process as cellular suicide. Of note, mice with homozygous deletions of either Ich-1 or Ich-3 genes display grossly normal development (Bergeron, L., M. Masayuki, S. Wang, and J. Yuan, unpublished results).
Cerebral ischemia induced by middle cerebral artery occlusion has been shown to result in increased expression of IL-1 [3 mRNA in the infarct territory (47) . Strikingly, treatment with the IL-1Ra decreased the ischemia-induced infarct size by 50% (48) . In addition, the brains of patients with Parkinson's disease, Alzheimer's disease, and Down's syndrome have elevated levels of IL-113 (49, 50) . These findings suggest that mature IL-113 is involved in mediating neuronal cell death pathways after ischemia, as well as in neurodegenerative diseases. This might be analogous to the notion that a cell needs to be "primed," creating the appropriate intracellular milieu (in neurons with trophic factor deprivation, in HeLa cells with hypoxia or G1/S phase arrest, and in L929 cells with TNF-00 for mature IL-113 to activate the cell death program. In vivo, the "primed" cell idea may translate to an ill cell that is a burden to the organism, and in an example of cellular altruism, the ICE pathway is activated, leading to the production of mature IL-113 and culminating in cellular suicide. However, uninjured cells may be protected by the IL-113 that is produced by the dying cells, at least in part by downregulating the IL-1 receptor, hence rescuing salvageable cells. Mature IL-113 plays a pivotal role in cellular homeostasis by modulating the apoptotic cascade and activating the immune system, processes that are respectively involved in the execution and elimination of unwanted cells.
